共 14 条
[1]
Salmon JT,Yla-Herttuala S,Yamamoto R,et al.Autoantibody against oxidised LDL and progression of caotid atherosclerosis. The Lancet . 1992
[2]
Griffith RL,Virella GT,Stevenson HC,et al.LDL metabolism by macrophages activated with LDL immune complexes: A possible mechanism of foam cell formation. The Journal of Experimental Medicine . 1988
[3]
witztum JL,Palinski W.Are immunological mechanisms relevant for the development of atherosclerosis. Clinical Immunology . 1999
[4]
Witztum JL,Steinberg D.Role of oxidized low density lipoprotein in atherogenesis. The Journal of Clinical Investigation . 1991
[5]
Diabetes[P]. 英国专利:GB201117172D0,2011-11-16
[6]
Gissinger C,Virella GT and Lopes-Virella MF.Erythrocyte-bound low density lipoprotein(LDL) immune complexes lead to cholesteryl ester accumulation in human monocyte-derived macrophages. Clinical Immunology and Immunopathology . 1991
[7]
Virella G,Koskinen S,Krings G,et al.Immunochemical characterization of purified human oxdized low-density lipoprotein antibodies. Clinical Immunology . 2000
[8]
Steinberg D,Parthasarathy S,Carew TE,et al.Byond cholesterol: Modifications of low density lipoprotein that increase its atherogenicity. The New England Journal of Medicine . 1989
[9]
Boyd HC,Gown AM,Wodfbaner,et al.Direct evodence for a protein recognized by a minoclonal antibody against oxidatively modified LDL in atherosclerosis lesions from a watanabe heritable hyperlipidemic rabbits. American Journal of Pathology . 1989
[10]
Stemme S,Faber B,Holm J,et al.T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proceedings of the National Academy of Sciences of the United States of America . 1995